跳到正文
原文
STAT· @statnews · X·· 12 天前AI 评分22
AI 导读

阿尔茨海默病治疗药物开发商 ProMis Neurosciences 的股价上周大幅下跌。深入探究其原因——以及这一理由是否站得住脚。https://trib.al/RHTAIsG

正文

Shares of ProMis Neurosciences, developer of a treatment for Alzheimer’s disease, sold off sharply last week. A closer look at the reason why — and whether it holds up. https://trib.al/RHTAIsG

来源:STAT · x.com